Company profile
Imbio, Inc.
Imbio, Inc. has 3 AI-enabled medical devices on the FDA list. The first decision was on June 13, 2023 and the most recent on December 19, 2024 (IQ-UIP). Its most common review panel is Radiology (3 devices).
3AI devices
2023First decision
2024Latest decision
1Specialties
Per year
20232024
By specialty
Related guides
Timeline
- IQ-UIP · Radiology · QWO
- Imbio PHA (4.0.0) · Radiology · QIH
- CAC Software · Radiology · JAK